162 related articles for article (PubMed ID: 10555101)
1. Lambert-Eaton myasthenic syndrome associated with idiopathic thrombocytopenic purpura and diffuse panbronchiolitis: long-term remission after a course of intravenous immunoglobulin combined with low-dose prednisolone.
Takata T; Koide S; Ogata K; Motomura M; Yoshimura T; Hanajima R; Sakurai M; Kanazawa I
Am J Med Sci; 1999 Nov; 318(5):353-5. PubMed ID: 10555101
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of Lambert-Eaton syndrome treated with intravenous immunoglobulin.
Muchnik S; Losavio AS; Vidal A; Cura L; Mazia C
Muscle Nerve; 1997 Jun; 20(6):674-8. PubMed ID: 9149073
[TBL] [Abstract][Full Text] [Related]
3. Available treatment options for the management of Lambert-Eaton myasthenic syndrome.
Verschuuren JJ; Wirtz PW; Titulaer MJ; Willems LN; van Gerven J
Expert Opin Pharmacother; 2006 Jul; 7(10):1323-36. PubMed ID: 16805718
[TBL] [Abstract][Full Text] [Related]
4. Use of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome.
Peterlin BL; Flood W; Kothari MJ
J Am Osteopath Assoc; 2002 Dec; 102(12):682-4. PubMed ID: 12501987
[TBL] [Abstract][Full Text] [Related]
5. Using immunoglobulins in muscular disease treatment.
Pul R; Stangel M
Expert Opin Biol Ther; 2008 Aug; 8(8):1143-50. PubMed ID: 18613765
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP
Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309
[TBL] [Abstract][Full Text] [Related]
7. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
Illa I
J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intravenous immunoglobulin for treatment of Lambert-Eaton myasthenic syndrome without anti-presynaptic P/Q-type voltage-gated calcium channel antibodies: a case report.
Okada A; Koike H; Nakamura T; Motomura M; Sobue G
Neuromuscul Disord; 2015 Jan; 25(1):70-2. PubMed ID: 25444432
[TBL] [Abstract][Full Text] [Related]
9. [Combination therapy with low-dose cyclosporin A, azathiopurine, and prednisolone for a child with refractory chronic idiopathic thrombocytopenic purpura].
Matsubara K; Nigami H; Harigaya H; Tanaka T; Yura K; Nozaki H; Iwata A; Fukaya T
Rinsho Ketsueki; 2007 Mar; 48(3):235-9. PubMed ID: 17441482
[TBL] [Abstract][Full Text] [Related]
10. [Low-dose prednisolone therapy for idiopathic thrombocytopenic purpura].
Ohmine K; Izumi T; Muroi K; Shimizu R; Imagawa S; Komatsu N; Sasaki R; Hatake K; Miura Y; Ozawa K
Rinsho Ketsueki; 2000 Jan; 41(1):8-11. PubMed ID: 10695392
[TBL] [Abstract][Full Text] [Related]
11. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports.
Schneider I; Kornhuber ME; Hanisch F
J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033
[TBL] [Abstract][Full Text] [Related]
12. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins.
Buchwald B; Ahangari R; Weishaupt A; Toyka KV
Muscle Nerve; 2005 Apr; 31(4):487-94. PubMed ID: 15685615
[TBL] [Abstract][Full Text] [Related]
13. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
Newsom-Davis J
Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
[TBL] [Abstract][Full Text] [Related]
14. Treatment in Lambert-Eaton myasthenic syndrome.
Maddison P
Ann N Y Acad Sci; 2012 Dec; 1275():78-84. PubMed ID: 23278581
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of Lambert-Eaton myasthenic syndrome and autoimmune encephalitis with anti-CRMP5/CV2 and anti-GABAB receptor antibodies in small cell lung cancer: A case report.
Li H; Zhang A; Hao Y; Guan H; Lv Z
Medicine (Baltimore); 2018 May; 97(19):e0696. PubMed ID: 29742721
[TBL] [Abstract][Full Text] [Related]
16. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura.
Hedlund-Treutiger I; Henter JI; Elinder G
J Pediatr Hematol Oncol; 2003 Feb; 25(2):139-44. PubMed ID: 12571466
[TBL] [Abstract][Full Text] [Related]
17. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
Lorenzoni PJ; Scola RH; Lang B; Kay CS; Teive HA; Kowacs PA; Werneck LC
J Neurol Sci; 2008 Jul; 270(1-2):194-6. PubMed ID: 18374949
[TBL] [Abstract][Full Text] [Related]
18. High-dose dexamethasone therapy for a 14-month-old boy with refractory idiopathic thrombocytopenic purpura.
Watanabe A; Kakihara T; Yamamoto K; Kataoka S; Okada R; Tanaka A; Uchiyama M
Acta Paediatr Jpn; 1997 Jun; 39(3):368-70. PubMed ID: 9241904
[TBL] [Abstract][Full Text] [Related]
19. Current therapy for Lambert-Eaton myasthenic syndrome: development of 3,4-diaminopyridine phosphate salt as first-line symptomatic treatment.
Quartel A; Turbeville S; Lounsbury D
Curr Med Res Opin; 2010 Jun; 26(6):1363-75. PubMed ID: 20377318
[TBL] [Abstract][Full Text] [Related]
20. Treatment for Lambert-Eaton myasthenic syndrome.
Maddison P; Newsom-Davis J
Cochrane Database Syst Rev; 2003; (2):CD003279. PubMed ID: 12804456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
